Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.

Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.

Antimalarial drugs have usually been first deployed in areas of malaria endemicity at doses which were too low, particularly for high-risk groups such as young children and pregnant women. This may accelerate the emergence and spread of resistance, thereby shortening the useful life of the drug, but...

書誌詳細
第一著者:	White, N
フォーマット:	Journal article
言語:	English
出版事項:	2013

類似資料

Use of population pharmacokinetic‐pharmacodynamic modelling to inform antimalarial dose optimization in infants
著者:: Banda, CG, 等
出版事項: (2024)

Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
著者:: Kloprogge, F
出版事項: (2013)

Population Pharmacokinetics and Antimalarial Pharmacodynamics of Piperaquine in Patients With Plasmodium vivax Malaria in Thailand.
著者:: Tarning, J, 等
出版事項: (2014)

Population pharmacokinetics and antimalarial pharmacodynamics of piperaquine in patients with plasmodium vivax malaria in Thailand
著者:: Tarning, J, 等
出版事項: (2014)

Assessment of the pharmacodynamic properties of antimalarial drugs in vivo.
著者:: White, N
出版事項: (1997)

Mefloquine pharmacokinetic-pharmacodynamic models: implications for dosing and resistance.
著者:: Simpson, J, 等
出版事項: (2000)

Pharmacokinetic and Pharmacodynamic Considerations of Antibiotic Use in Neonates
著者:: Mario Regazzi, 等
出版事項: (2023-12-01)

Pharmacokinetic and pharmacodynamic considerations with psychiatric disorders and migraines
著者:: Emma C. Palmer, PharmD, BCPS, BCPP, 等
出版事項: (2024-06-01)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
著者:: White, N, 等
出版事項: (1999)

Antimalarial pharmacokinetics and treatment regimens.
著者:: White, N
出版事項: (1992)

Clinical pharmacokinetics of antimalarial drugs.
著者:: White, N
出版事項: (1985)

Mefloquine antimalarial prophylaxis in pregnancy: dose finding and pharmacokinetic study.
著者:: Nosten, F, 等
出版事項: (1990)

CLINICAL IMPORTANCE OF ANTIMALARIAL PHARMACOKINETICS
著者:: Karbwang, J, 等
出版事項: (1988)

Population pharmacokinetics of the antimalarial amodiaquine: A pooled analysis to optimize dosing
著者:: Ali, A, 等
出版事項: (2018)

Pharmacokinetic and pharmacodynamic principles: unique considerations for optimal design of neonatal clinical trials
著者:: Cindy Hoi Ting Yeung, 等
出版事項: (2024-01-01)

Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.
著者:: White, N
出版事項: (1994)

Pharmacokinetics and metabolism of the antimalarial piperaquine after intravenous and oral single doses to the rat.
著者:: Tarning, J, 等
出版事項: (2008)

Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N‐dimethyltryptamine – Implications for dose considerations
著者:: Emma Eckernäs, 等
出版事項: (2022-12-01)

Dosing optimization of rituximab for primary membranous nephropathy by population pharmacokinetic and pharmacodynamic study
著者:: Hao Liang, 等
出版事項: (2024-03-01)

Cancer Immunotherapy Dosing: A Pharmacokinetic/Pharmacodynamic Perspective
著者:: Félicien Le Louedec, 等
出版事項: (2020-10-01)

The pharmacokinetics and pharmacodynamics of esomeprazole in sheep after intravenous dosing
著者:: Joe S. Smith, 等
出版事項: (2023-05-01)

Pharmacokinetics and pharmacodynamics of repeat dosing of gabapentin in adult horses
著者:: Jenifer R. Gold, 等
出版事項: (2022-03-01)

Evaluation of Natalizumab Pharmacokinetics and Pharmacodynamics: Toward Individualized Doses
著者:: Jose M. Serra López-Matencio, 等
出版事項: (2021-10-01)

Dose optimisation based on pharmacokinetic/pharmacodynamic target of tigecycline
著者:: Bing Leng, 等
出版事項: (2021-06-01)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
著者:: White, N, 等
出版事項: (1999)

Improving pharmacokinetic-pharmacodynamic modeling to investigate anti-infective chemotherapy with application to the current generation of antimalarial drugs.
著者:: Katherine Kay, 等
出版事項: (2013-01-01)

Loading dose in antimalarial prophylaxis.
著者:: White, N
出版事項: (1985)

Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates
著者:: Yangyang Gao, 等
出版事項: (2025-01-01)

Pharmacokinetic and Pharmacodynamic Considerations for the Use of Monoclonal Antibodies in the Treatment of Bacterial Infections
著者:: Shun Xin Wang-Lin, 等
出版事項: (2018-01-01)

Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis
著者:: Deshpande, D, 等
出版事項: (2018)

Optimizing Antimicrobial Therapy by Integrating Multi-Omics With Pharmacokinetic/Pharmacodynamic Models and Precision Dosing
著者:: Hui-Yin Yow, 等
出版事項: (2022-06-01)

Dosing time optimization of antihypertensive medications by including the circadian rhythm in pharmacokinetic-pharmacodynamic models.
著者:: Javiera Cortés-Ríos, 等
出版事項: (2022-11-01)

Pharmacokinetic determinants of the window of selection for antimalarial drug resistance.
著者:: Stepniewska, K, 等
出版事項: (2008)

Considerations for Optimizing Dosing of Immunoglobulins Based on Pharmacokinetic Evidence
著者:: Iftekhar Mahmood, 等
出版事項: (2020-06-01)

Lefamulin dosing optimization using population pharmacokinetic and pharmacokinetic/pharmacodynamic assessment in Chinese patients with community-acquired bacterial pneumonia
著者:: Xingchen Bian, 等
出版事項: (2024-10-01)

Pharmacokinetics and pharmacodynamics of curcumin.
著者:: Sharma, R, 等
出版事項: (2007)

Pharmacokinetic and pharmacodynamic considerations for treating sarcoptic mange with cross-relevance to Australian wildlife
著者:: Kotaro Takano, 等
出版事項: (2023-04-01)

Dose Optimization of Combined Linezolid and Fosfomycin against Enterococcus by Using an In Vitro Pharmacokinetic/Pharmacodynamic Model
著者:: Jun Mao, 等
出版事項: (2021-12-01)

Pharmacokinetic evaluation and metabolite characterization of the antimalarial piperaquine in the rat
著者:: Tarning, J, 等
出版事項: (2007)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
著者:: Hirsh Elhence, 等
出版事項: (2022-12-01)